Disclosure of interest: Yonatan Danin: nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2568 - ESOC25-2327 NEUROSONOLOGICAL HYPERPERFUSION AFTER CAROTID STENTING: A RETROSPECTIVE STUDY Juan Alberto Aguilera Aguilera 1 , Jess Alberto Vizcaya Gaona 1 , Beatriz Rodriguez Garcia, 1 , Miriam Ravelo Leon 1 , Diana Stefania Gomez de la Torre Morales 1 , Juan Sebastin Rodrguez Carrillo 1 , Irene Diaz Diaz 1 , Mario Luz Esteve 1 , Laura Redondo 1 1 Salamanca University Hospital, Salamanca, Spain Background and Aims: Cerebral Hyperperfusion Syndrome (CHS) is a serious but rare complication that can occur after carotid revascularisation
Research shows 6 percent of people 60 years old and over are classed as deficient in vitamin B12, and this only increases with age
5-Amino-1MQ Inhibits the NNMT enzyme, increasing metabolic rate , promoting fat oxidation , and helping preserve lean muscle mass during fat loss phases
These drugs are commonly referred to as biased ligands. For instance, G protein-biased -opioid receptor (OR) agonists are of remarkable clinical relevance as they enhance analgesia effects and reduce adverse reactions associated with the activation of -arrestin pathways, in contrast to morphine
